Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Buy
+60,200
New +$21.5M 0.05% 324
2025
Q4
Sell
-8,700
Closed -$2.46M 3123
2025
Q3
$2.46M Sell
8,700
-2,200
-20% -$638K 0.01% 1035
2025
Q2
$3.04M Sell
10,900
-6,100
-36% -$1.73M 0.01% 743
2025
Q1
$5.3M Buy
17,000
+5,100
+43% +$1.51M 0.03% 415
2024
Q4
$3.1M Buy
+11,900
New +$3.53M 0.02% 573
2024
Q1
Sell
-2,200
Closed -$633K 2255
2023
Q4
$633K Buy
+2,200
New +$599K ﹤0.01% 1238
2023
Q3
Sell
-3,300
Closed -$732K 2356
2023
Q2
$732K Sell
3,300
-16,700
-84% -$3.88M 0.01% 1142
2023
Q1
$4.83M Buy
20,000
+15,500
+344% +$3.8M 0.06% 266
2022
Q4
$1.18M Buy
4,500
+800
+22% +$214K 0.02% 855
2022
Q3
$833K Buy
+3,700
New +$897K 0.01% 1052
2021
Q4
Sell
-1,400
Closed -$297K 3119
2021
Q3
$297K Buy
+1,400
New +$322K ﹤0.01% 2409
2020
Q4
Sell
-9,900
Closed -$2.52M 1804
2020
Q3
$2.52M Buy
+9,900
New +$2.45M 0.07% 184
2020
Q2
Sell
-3,700
Closed -$750K 1515
2020
Q1
$750K Buy
+3,700
New +$808K 0.05% 311
2019
Q4
Sell
-20,900
Closed -$4.04M 1127
2019
Q3
$4.04M Buy
+20,900
New +$4.01M 0.19% 83

Other funds holding AMGN

HRT Financial's AMGN Position: Q1 2026 in Review

HRT Financial opened a new position in Amgen (AMGN) in Q1 2026: 321,715 shares worth $113M. The stake represents 0.28% of the portfolio and ranks #49 among its holdings. This is a return to the name: HRT Financial previously reported a position in AMGN as recently as Q1 2025.

HRT Financial first reported a position in AMGN in Q3 2015 and has held it in 21 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • HRT Financial held 321,715 shares of Amgen worth $113M as of Q1 2026.
  • Amgen was a new HRT Financial position in Q1 2026.
  • Amgen made up 0.28% of HRT Financial's portfolio in Q1 2026, its #49 holding.
  • HRT Financial first reported a position in Amgen in Q3 2015 and has held it in 21 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.